Hosted on MSN
HeartBeam sets price for $10 million stock offering
SANTA CLARA, Calif. - HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company with a current market capitalization of approximately $60 million, has announced the pricing of its public offering ...
Radiation therapy is a common treatment for cancer, but could it also help treat dangerous heart rhythms? Mayo Clinic recently completed the first clinical trial in humans using proton beam therapy, a ...
Heartbeam Inc (NASDAQ:BEAT) shares are trading higher by 3.5% to $2.35 Tuesday, pulling back following the session high of $2.70. The earlier move higher came despite a lack of company-specific news ...
Seasoned MedTech Leader with Proven Track Record of Strategic Planning, Financial Stewardship and Commercial Success SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT), a medical ...
Successfully Met Clinical Endpoints in the VALID-ECG Pivotal Study Showing 93.4% Overall Diagnostic Agreement for Assessment of Arrhythmia Productive Discussions with FDA on 510(k) Submission for ...
Received FDA Clearance for the HeartBeam System – an At-Home, High-Fidelity Heart Monitoring Technology Commenced Early Access Program to Attain Key Insights and Establish Sales Funnel in Preparation ...
HeartBeam has secured US Food and Drug Administration (FDA) clearance for its 12-lead electrocardiogram (ECG) synthesis software, setting the arrhythmia assessment tool up for deployment in patients’ ...
SANTA CLARA, Calif.--(BUSINESS WIRE)-- HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, announced today ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, today announced new ...
Heartbeam, Inc. ( (BEAT)) has released its Q3 earnings. Here is a breakdown of the information Heartbeam, Inc. presented to its investors. HeartBeam, Inc. is an innovative medical technology company ...
ECG diagnostics software platform AccurKardia and cardiac medical technology company HeartBeam are joining forces to make AccurKardia's ECG analysis software available on HeartBeam's devices.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results